Biohaven
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Biohaven 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BHVN
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
CEOVladimir Coric
CEOVladimir Coric
Employees256
Employees256
HeadquartersNew Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded2022
Founded2022
Employees256
Employees256
BHVN Key Statistics
Market cap1.24B
Market cap1.24B
Price-Earnings ratio-1.26
Price-Earnings ratio-1.26
Dividend yield—
Dividend yield—
Average volume3.18M
Average volume3.18M
High today$9.68
High today$9.68
Low today$8.84
Low today$8.84
Open price$9.11
Open price$9.11
Volume3.31M
Volume3.31M
52 Week high$46.23
52 Week high$46.23
52 Week low$7.48
52 Week low$7.48
Stock Snapshot
The current Biohaven(BHVN) stock price is $9.57, with a market capitalization of 1.24B. The stock trades at a price-to-earnings (P/E) ratio of -1.26.
On 2025-12-04, Biohaven(BHVN) stock moved within a range of $8.84 to $9.68. With shares now at $9.57, the stock is trading +8.3% above its intraday low and -1.1% below the session's peak.
Trading volume for Biohaven(BHVN) stock has reached 3.31M, versus its average volume of 3.18M.
Over the past 52 weeks, Biohaven(BHVN) stock has traded between a high of $46.23 and a low of $7.48.
Over the past 52 weeks, Biohaven(BHVN) stock has traded between a high of $46.23 and a low of $7.48.
Analyst ratings
65%
of 17 ratingsBuy
64.7%
Hold
35.3%
Sell
0%
People also own
Based on the portfolios of people who own BHVN. This list is generated using Robinhood data, and it’s not a recommendation.